عربي
English
Quick links
Related sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password? Click here
Let us help you
Read about the latest topics.
Download the new version of the MOPH app 
for the latest updates on Coronavirus
 
Be Responsible
#Raise your voice
Send us any Fraudulent Action or Enquiry so we can ALL contribute to make a Difference

Lebanon National Drugs Database

This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health
 
You can search in the form below for information related to drugs including Subsidy percentage

​Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
 
    1
    2
    3
    4
    5
    6
    ...
    12
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC Name B/G Ingredients Dosage Form Price
S01EE04 TRAVOPROST BIOGARAN Travoprost - 40mcg/ml 40mcg/ml Drops solution 564,414 L.L
D06AX TRIPLE ANTIBIOTIC ORIGINAL OINTMENT Bacitracin - 400U, Neomycin (sulfate) - 3.5mg, Polymyxin B (sulfate) - 5000U 580,540 L.L
L04AX02 THALIDOMIDE BMS B Thalidomide - 50mg 50mg Capsule 27,387,764 L.L
S01EE04 TRAVATAN B Travoprost - 40mcg/ml 0.004% Drops solution 806,306 L.L
J05AH02 TAMIFLU B Oseltamivir (phosphate) - 75mg 75mg Capsule 1,464,788 L.L
J05AH02 TAMIFLU B Oseltamivir (phosphate) - 75mg 75mg Capsule 1,464,788 L.L
A02AC10 TUMS EXTRA STRENGTH 750 ASSORTED FRUIT B Calcium carbonate - 750mg Tablet, chewable 421,967 L.L
L01EA03 TASIGNA B Nilotinib - 200mg 200mg Capsule 380,020,484 L.L
C09AA05 TRITACE B Ramipril - 2.5mg 2.5mg Tablet 263,393 L.L
L01EA03 TASIGNA B Nilotinib - 150mg 150mg Capsule 298,428,304 L.L
J05AR03 TRUVADA B Emtricitabine - 200mg, Tenofovir disoproxil - 245mg Tablet, film coated 8,349,642 L.L
L01XK04 TALZENNA B Talazoparib - 1mg 1mg Capsule 6,585,777 L.L
L01XK04 TALZENNA B Talazoparib - 0.25mg 0.25mg Capsule 2,195,248 L.L
C09AA05 TRITACE B Ramipril - 5mg 5mg Tablet 509,316 L.L
J05AR13 TRIUMEQ B Dolutegravir - 50mg, Abacavir sulfate - 600mg, Lamivudine - 300mg Tablet, film coated 1,240,711 L.L
S01XA20 TEARS NATURALE B Duasorb - 0.4% 0.4% Drops solution 189,482 L.L
C09AA05 TRITACE B Ramipril - 10mg 10mg Tablet 689,391 L.L
L01EB02 TARCEVA B Erlotinib (HCl) - 100mg 100mg Tablet, film coated 118,438,748 L.L
L01EB02 TARCEVA B Erlotinib (HCl) - 100mg 100mg Tablet, film coated 104,730,039 L.L
J05AX12 TIVICAY B Dolutegravir - 50mg 50mg Tablet, film coated 894,064 L.L
S02AA30 TYOTOCIN B Hexylresorcinol - 0.1%, Antipyrine - 5%, Benzocaine - 1.25%, Tyrothricin - 0.05% Drops solution 409,552 L.L
L04AX07 TECFIDERA B Dimethyl Fumarate - 120mg 120mg Capsule, hard, gastro-resistant 6,620,156 L.L
L01EB02 TARCEVA B Erlotinib (HCl) - 150mg 150mg Tablet, film coated 147,869,593 L.L
A10BH05 TRAJENTA B Linagliptin - 5mg 5mg Tablet, film coated 3,213,127 L.L
L01EB02 TARCEVA B Erlotinib (HCl) - 150mg 150mg Tablet, film coated 139,963,417 L.L
L04AX07 TECFIDERA B Dimethyl Fumarate - 240mg 240mg Capsule, hard, gastro-resistant 92,811,738 L.L
B02BC30-V03AK TISSEEL LYO B Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml Injectable powder for solution + solution 876,507 L.L
L01EB04 TAGRISSO B Osimertinib - 80mg 80mg Tablet, film coated 603,192,941 L.L
B02BC30-V03AK TISSEEL LYO B Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml Injectable powder for solution + solution 10,169,988 L.L
B02BC30-V03AK TISSEEL LYO B Fibrinogen, human (clottable protein) (I) - 91mg/ml, Aprotinin, synthetic (I) - 3000KIU/ml, Thrombin, Human (II) - 500IU/ml, Calcium chloride (II) - 40?mol/ml Injectable powder for solution + solution 13,394,024 L.L
    1
    2
    3
    4
    5
    6
    ...
    12
Sitemap
© Copyrights reserved to Ministry of Public Health 2024